There are several ongoing trials of Lp(a)-lowering medicines in clinical trials for atherosclerotic cardiovascular disease and some for AS (NCT05646381), but while robust human genetic evidence exists for Europeans, the evidence among non-Europeans remains sparse. The gene discussed is LPA; the disease is aortic stenosis.